Literature DB >> 27195270

Implementation and organization of lung cancer screening.

Jesper Holst Pedersen1, Haseem Ashraf1.   

Abstract

CT screening for lung cancer is now being implemented in the US and China on a widespread national scale but not in Europe so far. The review gives a status for the implementation process and the hurdles to overcome in the future. It also describes the guidelines and requirements for the structure and components of high quality CT screening programs. These are essential in order to achieve a successful program with the fewest possible harms and a possible mortality benefit like that documented in the American National Lung Screening Trial (NLST). In addition the importance of continued research in CT screening methods is described and discussed with focus on the great potential to further improve this method in the future for the benefit of patients and society.

Entities:  

Keywords:  CT screening; Lung cancer; implementation; organization

Year:  2016        PMID: 27195270      PMCID: PMC4860485          DOI: 10.21037/atm.2016.03.59

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  47 in total

1.  Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial.

Authors:  Frederick J Larke; Randell L Kruger; Christopher H Cagnon; Michael J Flynn; Michael M McNitt-Gray; Xizeng Wu; Phillip F Judy; Dianna D Cody
Journal:  AJR Am J Roentgenol       Date:  2011-11       Impact factor: 3.959

Review 2.  CT screening for lung cancer: Is the evidence strong enough?

Authors:  J K Field; A Devaraj; S W Duffy; D R Baldwin
Journal:  Lung Cancer       Date:  2015-11-30       Impact factor: 5.705

Review 3.  National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Lung Cancer Screening.

Authors:  Douglas E Wood
Journal:  Thorac Surg Clin       Date:  2015-01-28       Impact factor: 1.750

4.  Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation.

Authors:  Nichole T Tanner; Mulugeta Gebregziabher; Chanita Hughes Halbert; Elizabeth Payne; Leonard E Egede; Gerard A Silvestri
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

5.  Definition of a positive test result in computed tomography screening for lung cancer: a cohort study.

Authors:  Claudia I Henschke; Rowena Yip; David F Yankelevitz; James P Smith
Journal:  Ann Intern Med       Date:  2013-02-19       Impact factor: 25.391

6.  Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

Authors:  Nanda Horeweg; Carlijn M van der Aalst; Erik Thunnissen; Kristiaan Nackaerts; Carla Weenink; Harry J M Groen; Jan-Willem J Lammers; Joachim G Aerts; Ernst T Scholten; Joost van Rosmalen; Willem Mali; Matthijs Oudkerk; Harry J de Koning
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

7.  Performance of ACR Lung-RADS in a clinical CT lung screening program.

Authors:  Brady J McKee; Shawn M Regis; Andrea B McKee; Sebastian Flacke; Christoph Wald
Journal:  J Am Coll Radiol       Date:  2014-08-28       Impact factor: 5.532

Review 8.  Issues with implementing a high-quality lung cancer screening program.

Authors:  James L Mulshine; Thomas A D'Amico
Journal:  CA Cancer J Clin       Date:  2014-06-27       Impact factor: 508.702

9.  ESR/ERS white paper on lung cancer screening.

Authors:  Hans-Ulrich Kauczor; Lorenzo Bonomo; Mina Gaga; Kristiaan Nackaerts; Nir Peled; Mathias Prokop; Martine Remy-Jardin; Oyunbileg von Stackelberg; Jean-Paul Sculier
Journal:  Eur Radiol       Date:  2015-05-01       Impact factor: 5.315

10.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Authors:  J K Field; S W Duffy; D R Baldwin; D K Whynes; A Devaraj; K E Brain; T Eisen; J Gosney; B A Green; J A Holemans; T Kavanagh; K M Kerr; M Ledson; K J Lifford; F E McRonald; A Nair; R D Page; M K B Parmar; D M Rassl; R C Rintoul; N J Screaton; N J Wald; D Weller; P R Williamson; G Yadegarfar; D M Hansell
Journal:  Thorax       Date:  2015-12-08       Impact factor: 9.139

View more
  5 in total

Review 1.  The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries.

Authors:  Eduardo Edelman Saul; Raquel B Guerra; Michelle Edelman Saul; Laercio Lopes da Silva; Gabriel F P Aleixo; Raquel M K Matuda; Gilberto Lopes
Journal:  Nat Cancer       Date:  2020-11-30

Review 2.  YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.

Authors:  Federica Lo Sardo; Sabrina Strano; Giovanni Blandino
Journal:  Cancers (Basel)       Date:  2018-05-06       Impact factor: 6.639

3.  The KLF6 splice variant KLF6-SV1 promotes proliferation and invasion of non-small cell lung cancer by up-regultating PI3K-AKT signaling pathway.

Authors:  Nan Zhang; Qian-Qian Yan; Lu Lu; Jing-Bo Shao; Zhi-Gang Sun
Journal:  J Cancer       Date:  2019-08-29       Impact factor: 4.207

4.  DeepLN: an artificial intelligence-based automated system for lung cancer screening.

Authors:  Jixiang Guo; Chengdi Wang; Xiuyuan Xu; Jun Shao; Lan Yang; Yuncui Gan; Zhang Yi; Weimin Li
Journal:  Ann Transl Med       Date:  2020-09

Review 5.  Challenges in Lung Cancer Screening in Latin America.

Authors:  Luis E Raez; Amanda Nogueira; Edgardo S Santos; Ricardo Sales Dos Santos; Juliana Franceschini; David Arias Ron; Mark Block; Nise Yamaguchi; Christian Rolfo
Journal:  J Glob Oncol       Date:  2018-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.